Primary Navigation for the CDC Web Site
CDC en Español
Prostate Cancer
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
divider
 View by Topic
bullet Basic Information
bullet Statistics
bullet What CDC is Doing
bullet Informed Decision Making
bullet Publications
bullet Screening Decision Guide
bullet Screening Decision Guide for African Americans
bullet Sharing the Decision Slide Set
bullet Partners

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

Sharing the Decision Slide Set: Slide 23

Talking Points and Text Description of Slide

Previous Slide Index View Thumbnail View Next Slide
Slide 23
Previous Slide Index View Thumbnail View Next Slide

Slide 23 — Do We Extend Men’s Lives by Screening for Prostate Cancer?

Talking Points

Do we extend men's lives by screening for prostate cancer?

Given the available clinical evidence, the only conclusion is that we honestly do not know, at this time, whether detecting early tumors through PSA testing reduces prostate cancer mortality and extends men's lives.

Now let's consider the side effects of PSA testing and early treatment.

Text Description of Slide

Please refer to the "Talking Points" above.

Page last reviewed: September 26, 2006
Page last updated: September 26, 2006
Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
USA.govDHHS Department of Health
and Human Services